Deloitte wins Project of the Year for helping Mologic hyperscale

08 November 2021 3 min. read

At the MCA Awards 2021, Deloitte took home multiple awards. This included picking up the flagship ‘Project of the Year’ prize for its pro-bono support to Mologic.

Mologic is a UK-based diagnostic-technologies expert. The social enterprise works to accelerate access to innovative technologies and products for epidemics and neglected diseases for all nations. During the Covid-19 outbreak, this has seen it become one of the world’s leading producers of the lateral flow test.

In early 2020, as news of the coronavirus spread ahead of the outbreak, the rush to craft a cost-efficient rapid diagnostic test (RDT) quickly got underway. Weeks before the World Health Organisation declared Covid-19 a global pandemic, Mologic was already refining an RDT which could detect antibodies impacted by the virus in just 10 minutes. While the science was what Mologic specialised in, however, it needed help to rapidly scale production for global markets – in particular for countries with limited healthcare infrastructure and support.

This saw Deloitte engaged by the company. Mologic aimed to scale production in the UK, and secure a supply chain for product development and distribution to low-income settings, and Deloitte recognised supporting the Bedford-based SME in doing that could make a real difference in the combat of the pandemic. Working mostly pro bono, this saw Deloitte draw expertise in programme management, operations transformation, finance, manufacturing and supply chain to support Mologic in meeting its objectives.

At the same time, Mologic was keen to foster self-sufficiency at a time of great uncertainty through distributed production – jointly in Europe and Africa. Widespread supply chain disruption and building a distribution network to get the test to those who needed it presented key challenges to this, while Mologic it also needed guidance and support in developing a process and manufacturing facility that could be deployed in Africa. To this end, the Deloitte team leveraged its global network to help build the necessary ecosystem.

The Deloitte team supported the financial planning for a manufacturing facility in Senegal – supporting the development of skills locally. At the same time, it also built sustainable critical capacity in Africa – vital for the continent’s response to the pandemic and future events and offering security of supply for the region. Meanwhile, in the UK, the Big Four firm enabled Mologic to bring its Covid-19 test to market four weeks earlier than originally planned, and expand production by 1,000%.

Deloitte wins Project of the Year for helping Mologic hyperscale

This rapid success also laid the groundwork for the Mologic rapid antigen test to quickly follow. Mologic’s RDT antigen test has excellent performance in FIND’s independent evaluations, with an estimated 90% sensitivity and 100% specificity, and is a market leader. The greatest benefit of Mologic’s RDT will be felt in resource-limited settings where it will enable nations to upscale testing to understand local epidemiology and direct interventions.

The work by Deloitte was recently lauded by the annual MCA Awards. Overall Project of the Year, and the International category, were handed to Deloitte for its work with Mologic.

Commenting on all the winners of the 2021 edition, Tamzen Isacsson, Chief Executive of the MCA, said, “So many of the entries tell of the ingenuity, commitment and skill of our consultants which makes us a world leading industry. And so many show how the consultancy sector responded to the Covid-19 pandemic. The ability to deliver more services remotely released talent around the country and saw those talents being used not just in this country but around the globe. The faith clients have shown in the consulting sector in the most difficult of times has been vital.”